Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated May 2, 2023 (3 years ago)

VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-264-25

Affected NDC 71170-0264-25

Compare with the code on your package — it is the most precise check available.

Drug: Vancomycin

Recalling firm
Apollo Care, LLC
NDC code
71170-264-25
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0639-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Vancomycin recalls

See all
Class II · Moderate risk

Vancomycin HCL

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5082-01 D-0442-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5085-01 D-0441-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5083-01 D-0440-2026

Other recalls by Apollo Care, LLC

All 2023 recalls
Class II · Moderate risk

SEMAGLUTIDE 20mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-724-04 D-0757-2026
Class II · Moderate risk

SEMAGLUTIDE 10mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-722-02 D-0756-2026
Class II · Moderate risk

SEMAGLUTIDE 7.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-721-01 D-0755-2026
Class II · Moderate risk

SEMAGLUTIDE 5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-712-03 D-0754-2026